Recombinant CD19 (Denintuzumab Biosimilar) antibody

Catalog No. ABIN7675914

The Human Monoclonal anti-CD19 (Denintuzumab Biosimilar) antibody is suitable to detect CD19 (Denintuzumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant CD19 (Denintuzumab Biosimilar) antibody (ABIN7675914)

Target: CD19 (Denintuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD19 (Denintuzumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD19 (Denintuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD19 Reference Antibody (denintuzumab)

Characteristics: Anti-CD19 Reference Antibody (denintuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD19 (Denintuzumab Biosimilar)

Target: CD19 (Denintuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P15391